NOTCH1 inactivating mutation mediates sensitivity to PI3K/mTOR inhibitors in head and neck squamous cell carcinoma

被引：0
|
作者：
Johnson, Faye M.
Sambandam, Vaishnavi
Shen, Li
Zhang, Ming
Saigal, Rishi
Tong, Pan
Mazumdar, Tuhina
Byers, Lauren A.
Pickering, Curtis
Myers, Jeffrey N.
Wang, Jing
Frederick, Mitchell
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-393
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
393
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Identification of NOTCH1 inactivating mutation as a therapeutic vulnerability to PI3K/mTOR pathway inhibition in head and neck squamous cell carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Tong, Pan
    Mazumdar, Tuhina
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Frederick, Mitchell
    Johnson, Faye M.
    CANCER RESEARCH, 2017, 77
  • [2] Integrative drug sensitivity analysis of PI3K/mTOR pathway inhibitors in Head and Neck Squamous Cell Carcinoma (HNSCC)
    Sambandam, Vaishnavi
    Shen, Li
    Zhang, Ming
    Saigal, Rishi
    Byers, Lauren A.
    Pickering, Curtis
    Myers, Jeffrey N.
    Wang, Jing
    Johnson, Faye M.
    CANCER RESEARCH, 2015, 75
  • [3] PDK1 drives susceptibility of NOTCH1 mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition
    Sambandam, Vaishnavi
    Shen, Li
    Peng, Shaohua
    Mazumdar, Tuhina
    Pickering, Curtis
    Myers, Jeffrey
    Wang, Jing
    Frederick, Mitchell
    Johnson, Faye
    CANCER RESEARCH, 2019, 79 (13)
  • [4] Susceptibility of NOTCH1 mutant head and neck squamous carcinoma to PI3K/mTOR pathway inhibition via PDK1
    Sambandam, Vaishnavi
    Frederick, Mitchell J.
    Shen, Li
    Tong, Pan
    Rao, Xiayu
    Peng, Shaohua
    Mazumdar, Tuhina
    Li, Quili
    Pickering, Curtis R.
    Myers, Jeffery N.
    Wang, Jing
    Johnson, Faye M.
    MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 50 - 51
  • [5] PDK1 Mediates NOTCH1-Mutated Head and Neck Squamous Carcinoma Vulnerability to Therapeutic PI3K/mTOR Inhibition
    Sambandam, Vaishnavi
    Frederick, Mitchell J.
    Shen, Li
    Tong, Pan
    Rao, Xiayu
    Peng, Shaohua
    Singh, Ratnakar
    Mazumdar, Tuhina
    Huang, Chenfei
    Li, Qiuli
    Pickering, Curtis R.
    Myers, Jeffery N.
    Wang, Jing
    Johnson, Faye M.
    CLINICAL CANCER RESEARCH, 2019, 25 (11) : 3329 - 3340
  • [6] The Role of the PI3K/Akt/mTOR Axis in Head and Neck Squamous Cell Carcinoma
    Jiang, Qian
    Xiao, Jingyi
    Hsieh, Yao-Ching
    Kumar, Neha Love
    Han, Lei
    Zou, Yuntao
    Li, Huang
    BIOMEDICINES, 2024, 12 (07)
  • [7] Targeting the PI3K/AKT/mTOR pathway in squamous cell carcinoma of the head and neck
    Simpson, Daniel R.
    Mell, Loren K.
    Cohen, Ezra E. W.
    ORAL ONCOLOGY, 2015, 51 (04) : 291 - 298
  • [8] Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1
    Agrawal, Nishant
    Frederick, Mitchell J.
    Pickering, Curtis R.
    Bettegowda, Chetan
    Chang, Kyle
    Li, Ryan J.
    Fakhry, Carole
    Xie, Tong-Xin
    Zhang, Jiexin
    Wang, Jing
    Zhang, Nianxiang
    El-Naggar, Adel K.
    Jasser, Samar A.
    Weinstein, John N.
    Trevino, Lisa
    Drummond, Jennifer A.
    Muzny, Donna M.
    Wu, Yuanqing
    Wood, Laura D.
    Hruban, Ralph H.
    Westra, William H.
    Koch, Wayne M.
    Califano, Joseph A.
    Gibbs, Richard A.
    Sidransky, David
    Vogelstein, Bert
    Velculescu, Victor E.
    Papadopoulos, Nickolas
    Wheeler, David A.
    Kinzler, Kenneth W.
    Myers, Jeffrey N.
    SCIENCE, 2011, 333 (6046) : 1154 - 1157
  • [9] PI3K Inhibition for Squamous Cell Head and Neck Carcinoma
    Desilets, Antoine
    Soulieres, Denis
    CANCER JOURNAL, 2022, 28 (05): : 369 - 376
  • [10] Oral dual PI3K/mTOR inhibitor bimiralisib demonstrates tolerability and a signal of activity in head and neck squamous cell cancer with NOTCH1 loss -of-function mutation
    Janku, Filip
    Johnson, Faye M.
    Opyrchal, Mateusz
    Dowlati, Afshin
    Hierro, Cinta
    Forester, Martin
    Blagden, Sarah P.
    Wicki, Andreas
    Schmitz, Debora
    Adjei, Alex A.
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
12345